Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Correction: Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.
Journal: Blood cancer journal
Published: August 07, 2026
Prognostic impact of lymphocyte kinetics and immune composition during bispecific antibody therapy in relapsed/refractory multiple myeloma.
Journal: Blood cancer journal
Published: April 17, 2026
Methylome differences among barley inbreds and their association with genomic, transcriptomic, and phenotypic variation.
Journal: Journal of experimental botany
Published: July 11, 2025
Genetic architecture and cellular basis of flag leaf size in barley.
Journal: Journal of experimental botany
Published: May 20, 2025
The efficacy of teclistamab in patients with multiple myeloma and secondary plasma cell leukemia.
Journal: Blood advances
Published: April 01, 2025
Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.
Journal: Blood cancer journal
Published: January 11, 2025
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies.
Journal: British journal of haematology
Published: June 13, 2024
Last Updated: 09/26/2026